Low-dose hydrocortisone in chronic fatigue syndrome: a randomised crossover trial.
Low-dose hydrocortisone in chronic fatigue syndrome: a randomised crossover trial. Read More »
Cleare AJ et al. (1999) Low-dose hydrocortisone in chronic fatigue […]
Research Papers
Treating patients suffering from myalgic encephalopathy/chronic fatigue syndrome (ME/CFS) with sodium dichloroacetate: An open-label, proof-of-principle pilot trial.
Comhaire F (2018a) Treating patients suffering from myalgic encephalopathy/chronic fatigue
Why do some ME/CFS patients benefit from treatment with sodium dichloroacetate, but others do not?
Comhaire F (2018b) Why do some ME/CFS patients benefit from
The Role of Immunity and Inflammation in ME/ CFS and Post-COVID Syndrome: Implications for Treatment.
Comhaire F (2022) The Role of Immunity and Inflammation in
Red blood cell magnesium and chronic fatigue syndrome.
Red blood cell magnesium and chronic fatigue syndrome. Read More »
Cox IM et al. (1991) Red blood cell magnesium and
Off label use of Aripiprazole shows promise as a treatment for Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS): a retrospective study of 101 patients treated with a low dose of Aripiprazole.
Crosby, LD et al. (2021) Off label use of Aripiprazole
Combined use of SSRIs and NSAIDs increases the risk of gastrointestinal adverse effects.
Combined use of SSRIs and NSAIDs increases the risk of gastrointestinal adverse effects. Read More »
de Jong JC et al. (2003) Combined use of SSRIs
Clinical Improvement in Chronic Fatigue Syndrome Is Associated with Enhanced Natural Killer Cell-Mediated Cytotoxicity: The Results of a Pilot Study with Isoprinosine®.
Diaz-Mitoma F et al. (2003) Clinical Improvement in Chronic Fatigue
A Randomized, Double-Blind Trial of Nystatin Therapy for the Candidiasis Hypersensitivity Syndrome.
Dismukes WE et al. (1990) A Randomized, Double-Blind Trial of
Midodrine: use and current status in the treatment of hypotension.
Midodrine: use and current status in the treatment of hypotension. Read More »
Doyle JF et al. (2012) Midodrine: use and current status
Efficacy of Low-Dose Naltrexone and Predictors of Treatment Success or Discontinuation in Fibromyalgia and Other Chronic Pain Conditions: A Fourteen-Year, Enterprise-Wide Retrospective Analysis.
Driver CN and D�Souza RS (2023) Efficacy of Low-Dose Naltrexone
Gamma globulin therapy for chronic mononucleosis syndrome.
Gamma globulin therapy for chronic mononucleosis syndrome. Read More »
DuBois R . (1986) Gamma globulin therapy for chronic mononucleosis
Opioids for chronic musculoskeletal pain.
Opioids for chronic musculoskeletal pain. Read More »
Dunn KM and Hay EM. (2010) Opioids for chronic musculoskeletal
Clinical impact of B-cell depletion with the anti-CD20 antibody rituximab in chronic fatigue syndrome: a preliminary case series.
Fluge � and Mella O . (2009) Clinical impact of
Benefit from B-Lymphocyte Depletion Using the Anti-CD20 Antibody Rituximab in Chronic Fatigue Syndrome. A Double-Blind and Placebo- Controlled Study.
Fluge � et al. (2011) Benefit from B-Lymphocyte Depletion Using
B-Lymphocyte Depletion in Myalgic Encephalopathy/Chronic Fatigue Syndrome. An Open-Label Phase II Study with Rituximab Maintenance Treatment.
Fluge � et al. (2015) B-Lymphocyte Depletion in Myalgic Encephalopathy/Chronic
B-Lymphocyte Depletion in Patients With Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: A Randomized, Double-Blind, Placebo-Controlled Trial.
Fluge � et al. (2019) B-Lymphocyte Depletion in Patients With
The PACE trial: It’s time to broaden perceptions and move on.
The PACE trial: It’s time to broaden perceptions and move on. Read More »
Petrie KJ and Weinman J. (2017) The PACE trial: It’s
Expression of Concern: Adaptive Pacing, Cognitive Behaviour Therapy, Graded Exercise, and Specialist Medical Care for Chronic Fatigue Syndrome: A Cost-Effectiveness Analysis.
PLOS ONE Editors, The (2017) Expression of Concern: Adaptive Pacing,